Disease duration and severity impacts on long-term cardiovascular events in Japanese patients with rheumatoid arthritis

Journal of Cardiology

Volumn 64, Issue 5, 2014, Pages 366-370

  Masuda, Hiroshi ^a   Miyazaki, Tetsuro ^a   Shimada, Kazunori ^a   Tamura, Naoto ^a   Matsudaira, Ran ^a   Yoshihara, Takuma ^a   Ohsaka, Hiromichi ^a   Sai, Eiryu ^a   Matsumori, Rie ^a   Fukao, Kosuke ^a   Hiki, Makoto ^a   Kume, Atsumi ^a   Kiyanagi, Takashi ^a   Takasaki, Yoshinari ^a   Daida, Hiroyuki ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiovascular disease; Inflammation; Risk factors

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY RISK; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEART DEATH; HUMAN; INCIDENCE; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MORBIDITY; PHYSICAL DISABILITY; RHEUMATOID ARTHRITIS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; COMPLICATION; DISABLED PERSON; FOLLOW UP; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME;

AGED; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; DISABLED PERSONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84912019955     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2014.02.018     Document Type: Article

References (36)

1. Ku I.A., Imboden J.B., Hsue P.Y., Ganz P. Rheumatoid arthritis: model of systemic inflammation driving atherosclerosis. Circ J 2009, 73:977-985.
2. Solomon D.H., Karlson E.W., Rimm E.B., Cannuscio C.C., Mandl L.A., Manson J.E., Stampfer M.J., Curhan G.C. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003, 107:1303-1307.
3. Solomon D.H., Curhan G.C., Rimm E.B., Cannuscio C.C., Karlson E.W. Cardiovascular risk factors in women with and without rheumatoid arthritis. Arthritis Rheum 2004, 50:3444-3449.
4. Maradit-Kremers H., Crowson C.S., Nicola P.J., Ballman K.V., Roger V.L., Jacobsen S.J., Gabriel S.E. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005, 52:402-411.
5. Chung C.P., Oeser A., Raggi P., Gebretsadik T., Shintani A.K., Sokka T., Pincus T., Avalos I., Stein C.M. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum 2005, 52:3045-3053.
6. Nicola P.J., Crowson C.S., Maradit-Kremers H., Ballman K.V., Roger V.L., Jacobsen S.J., Gabriel S.E. Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum 2006, 54:60-67.
7. Peters M.J., Symmons D.P., McCarey D., Dijkmans B.A., Nicola P., Kvien T.K., McInnes I.B., Haentzschel H., Gonzalez-Gay M.A., Provan S., Semb A., Sidiropoulos P., Kitas G., Smulders Y.M., Soubrier M., et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010, 69:325-331.
8. Wallberg-Jonsson S., Ohman M.L., Dahlqvist S.R. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol 1997, 24:445-451.
9. Avina-Zubieta J.A., Choi H.K., Sadatsafavi M., Etminan M., Esdaile J.M., Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008, 59:1690-1697.
10. Watson D.J., Rhodes T., Guess H.A. All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. J Rheumatol 2003, 30:1196-1202.
11. Peters M.J., van Halm V.P., Voskuyl A.E., Smulders Y.M., Boers M., Lems W.F., Visser M., Stehouwer C.D., Dekker J.M., Nijpels G., Heine R., Dijkmans B.A., Nurmohamed M.T. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease. A prospective study. Arthritis Rheum 2009, 61:1571-1579.
12. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., Healey L.A., Kaplan S.R., Liang M.H., Luthra H.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
13. Braunwald E. Unstable angina. A classification. Circulation 1989, 80:410-414.
14. Matsumori R., Shimada K., Kiyanagi T., Hiki M., Fukao K., Hirose K., Ohsaka H., Miyazaki T., Kume A., Yamada A., Takagi A., Ohmura H., Miyauchi K., Daida H. Clinical significance of the measurements of urinary liver-type fatty acid binding protein levels in patients with acute coronary syndrome. J Cardiol 2012, 60:168-173.
15. Konishi H., Kasai T., Miyauchi K., Kajimoto K., Kubota N., Dohi T., Amano A., Daida H. Association of low glomerular filtration rate with the incidence of stroke in patients following complete coronary revascularization. Circ J 2011, 75:2372-2378.
16. Matsuzaki M., Kita T., Mabuchi H., Matsuzawa Y., Nakaya N., Oikawa S., Saito Y., Sasaki J., Shimamoto K., Itakura H., J-LIT Study Group Japan Lipid Intervention Trial. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ J 2002, 66:1087-1095.
17. Mabuchi H., Kita T., Matsuzaki M., Matsuzawa Y., Nakaya N., Oikawa S., Saito Y., Sasaki J., Shimamoto K., Itakura H., J-LIT Study Group Japan Lipid Intervention Trial. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT). Circ J 2002, 66:1096-1100.
18. Teramoto T., Sasaki J., Ishibashi S., Birou S., Daida H., Dohi S., Egusa G., Hiro T., Hirobe K., Iida M., Kihara S., Kinoshita M., Maruyama C., Ohta T., Okamura T., et al. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan-2012 version. J Atheroscler Thromb 2013, 20:517-523.
19. Nakamura Y., Yamamoto T., Okamura T., Kadowaki T., Hayakawa T., Kita Y., Saitoh S., Okayama A., Ueshima H. NIPPON DATA 80 Research Group, Combined cardiovascular risk factors and outcome: NIPPON DATA80, 1980-1994. Circ J 2006, 70:960-964.
20. Kao A.H., Krishnaswami S., Cunningham A., Edmundowicz D., Morel P.A., Kuller L.H., Wasko M.C. Subclinical coronary artery calcification and relationship to disease duration in women with rheumatoid arthritis. J Rheumatol 2008, 35:61-69.
21. Del Rincon I., O'Leary D.H., Freeman G.L., Escalante A. Acceleration of atherosclerosis during the course of rheumatoid arthritis. Atherosclerosis 2007, 195:354-360.
22. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999, 138(5 Pt 2):S419-S420.
23. Pasceri V., Yeh E.T. A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 1999, 100:2124-2126.
24. Kaplan M.J. Cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol 2006, 18:289-297.
25. Kocabay G., Hasdemir H., Yildiz M. Evaluation of pulse wave velocity in systemic lupus erythematosus, rheumatoid arthritis and Behcet's disease. J Cardiol 2012, 59:72-77.
26. Choi H.K., Hernan M.A., Seeger J.D., Robins J.M., Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 2002, 359:1173-1177.
27. Avouac J., Allanore Y. Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs. Expert Opin Pharmacother 2008, 9:1121-1128.
28. Nishida K., Okada Y., Nawata M., Saito K., Tanaka Y. Induction of hyperadiponectinemia following long-term treatment of patients with rheumatoid arthritis with infliximab (IFX), an anti-TNF-alpha antibody. Endocr J 2008, 55:213-216.
29. Dixon W.G., Watson K.D., Lunt M., Hyrich K.L., British Society for Rheumatology Biologics Register Control Centre Consortium, Silman A.J., Symmons D.P., British Society for Rheumatology Biologics Register Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 2007, 56:2905-2912.
30. Nashel D.J. Is atherosclerosis a complication of long-term corticosteroid treatment. Am J Med 1986, 80:925-929.
31. Krishnan E., Lingala V.B., Singh G. Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis. Circulation 2004, 110:1774-1779.
32. Metsios G.S., Stavropoulos-Kalinoglou A., Veldhuijzen van Zanten J.J., Treharne G.J., Panoulas V.F., Douglas K.M., Koutedakis Y., Kitas G.D. Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review. Rheumatology (Oxford) 2008, 47:239-248.
33. Albert M.A., Glynn R.J., Ridker P.M. Effect of physical activity on serum C-reactive protein. Am J Cardiol 2004, 93:221-225.
34. Kasapis C., Thompson P.D. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 2005, 45:1563-1569.
35. McLaughlin T., Abbasi F., Lamendola C., Liang L., Reaven G., Schaaf P., Reaven P. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 2002, 106:2908-2912.
36. Metsios G.S., Stavropoulos-Kalinoglou A., Sandoo A., van Zanten J.J., Toms T.E., John H., Kitas G.D. Vascular function and inflammation in rheumatoid arthritis: the role of physical activity. Open Cardiovasc Med J 2010, 4:89-96.